About This Trend

Cabaletta Bio, Inc. (CABA) is a biotechnology company that focuses on the development of investigational therapies, including CD19-CAR T cell therapy. The company is known for its RESET clinical trials, which are being conducted to treat various diseases such as lupus, myositis, and systemic sclerosis.

The company's stock, CABA, is currently trending due to recent updates on its clinical trials and financial information, including pre-market trades and analyst estimates. Additionally, the term CABA is also being used in other contexts, such as in reference to the City of Perth Amboy and a sports league, but the primary reason for the trend is the biotechnology company's activities. .

---